The anti-inflammatory effects of photobiomodulation are mediated by cytokines: Evidence from a mouse model of inflammation

• Published in: Frontiers in neuroscience Vol. 17; p. 1150156
• Main Authors: Shamloo, Shirin, Defensor, Erwin, Ciari, Peter, Ogawa, Gaku, Vidano, Laura, Lin, Jennifer S., Fortkort, John A., Shamloo, Mehrdad, Barron, Annelise E.
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Research Foundation 06.04.2023; Frontiers Media S.A
• Subjects: Alzheimer's disease; Cytokines; Inflammasomes; Inflammation; Interleukin 1; Interleukin 10; Interleukin 18; Ischemia; Kinases; Light therapy; lipopolysaccharide (LPS); Lipopolysaccharides; Neurodegeneration; neurodegenerative disorders; neuroinflammation; Neuroscience; photobiomodulation (PBM); Plasma; Protein expression; Proteins; systemic inflammation; Traumatic brain injury; lipopolysaccharide (LPS); systemic inflammation; photobiomodulation (PBM); light therapy; neurodegenerative disorders; neuroinflammation

There is an urgent need for therapeutic approaches that can prevent or limit neuroinflammatory processes and prevent neuronal degeneration. Photobiomodulation (PBM), the therapeutic use of specific wavelengths of light, is a safe approach shown to have anti-inflammatory effects. The current study wa...